Sosa, E. C. (2012). Veno-occlusive disease in hematopoietic stem cell transplantation patients. Clinical Journal of Oncology Nursing, 16 (5), 507-513. doi:10.1188/12.CJON.507-513 Soto, M., Lalla, R. V., Gouveia, R. V., Zecchin, V. G., Seber, A. e Lopes, N. N. (2015). Pilot study on the efficacy of combined intraoral and extraoral low-level laser therapy for prevention of oral mucositis in pediatric patients undergoing hematopoietic stem cell transplantation. Photomedicine and Laser Surgery, 33 (11), 540–546. doi:10.1089/ pho.2015.3954 Spolarich, A. E. (2014). Risk management strategies for reducing oral adverse drug events. Journal of Evidence Based Dental Practice, 14 (suppl) , 87–94. doi:10.1016/j.jebdp.2014.04.009 Spunt, S. L., Irving, H., Frost, J., Sender, L., Guo, M., Yang, B., . . . Santana, V. M. (2010). Phase II, randomized, open-label study of pegfilgrastim-supported VDC/IE chemotherapy in pediatric sarcoma patients. Journal of Clinical Oncology, 28 (8), 1329-1336. doi:10.1200/ JCO.2009.24.8872 Steinherz, L. J., Graham, T., Hurwitz, R., Sondheimer, H., Schwartz, R. G., Shaffer, E., . . . Williams, R. (1992). Guidelines for cardiac monitoring of children during and after anthracycline therapy: Report of the cardiology committee of the Childrens Cancer Study Group . Pediatrics, 89 (5 Pt 1), 942–949. Steuber, A. (2015). Recognizing reversible posterior leukoencephalopathy syndrome . Nursing, 45 (12), 16–18. doi:10.1097/01. NURSE.0000473400.74424.db Stone, J. B. e DeAngelis, L. M. (2016). Cancer-treatment-induced neurotoxicity: Focus on newer treatments. Nature Reviews Clinical Oncology, 13(2), 92–105. doi:10.1038/nrclinonc.2015.152 Strouse, C., Richardson, P., Prentice, G., Korman, S., Hume, R., Nejadnik, B., . . . Saber, W. (2016). Defibrotide for treatment of severe veno- occlusive disease in pediatrics and adults: An exploratory analysis using data from the Center for International Blood and Marrow Transplant Research. Biology of Blood and Marrow Transplantation, 22 (7), 1306–1312. doi:10.1016/j.bbmt.2016.04.011 Stubblefield, M. D., Burstein, H. J., Burton, A. W., Custodio, C. M., Deng, G. E., Ho, M., . . . Von Roenn, J. H. (2009). NCCN task force report: Management of neuropathy in cancer. Journal of the National Comprehensive Cancer Network, 7 (suppl 5), s1–s25. Sung, L., Robinson, P., Treister, N., Baggott, C., Gibson, P., Tissing, W., . . . Dupuis, L. L. (2017). Guideline for the prevention of oral and oropharyngeal mucositis in children receiving treatment for cancer or undergoing haematopoietic stem cell transplantation. BMJ Supportive and Palliative Care, 7 (1), 7–16. doi:10.1136/bmjspcare-2014-000804 Susman, E. (2014). New NCCN guidelines for peripheral neuropathy. Oncology Times, 36 (8), 8–10. doi:10.1097/01.COT.0000446655.58574. d0 Tabbers, M. M., DiLorenzo, C., Berger, M. Y., Faure, C., Langendam, M. W., Nurko, S., . . . Benninga, M. A. (2014). Evaluation and treatment of functional constipation in infants and children: Evidence-based recommendations from ESPGHAN and NASPGHAN. Journal of Pediatric Gastroenterology and Nutrition, 58 (2), 258–272. doi:10.1097/MPG.0000000000000266 Tambasco, N., Mastrodicasa, E., Salvatori, C., Mancini, G., Romoli, M., Caniglia, M., . . . Verrotti, A. (2016). Prognostic factors in children with PRES and hematologic diseases. Acta Neurologica Scandinavica, 134 (6), 474–483. doi:10.1111/ane.12570 Tang, J. H., Tian, J. M., Sheng, M., Hu, S. Y., Li, Y., Zhang, L. Y., . . . Wang, Q. (2016). Study of posterior reversible encephalopathy syndrome in children with acute lymphoblastic leukemia after induction chemotherapy. Journal of Child Neurology, 31 (3), 279–284. doi:10.1177/0883073815589758 Tavil, B., Isgandarova, F., Bayhan, T., Unal, S., Kuskonmaz, B., Gumruk, F., & Cetin, M. (2016). Sorafenib-induced posterior reversible encephalopathy syndrome in a child with FLT3-ITD-positive acute myeloid leukemia. Journal of Pediatric Hematology Oncology , 38 (3), 240–242. doi:10.1097/MPH.0000000000000521
Tewari, P., Wallis, W., & Kebriaei, P. (2017). Manifestations and management of veno-occlusive disease/sinusoidal obstruction syndrome in the era of contemporary therapies. Clinical Advances in Hematology & Oncology, 15 (2), 130–139. Tofthagen, C., Visovsky, C. M., & Hopgood, R. (2013). Chemotherapy-induced peripheral neuropathy: An algorithm to guide nursing management. Clinical Journal of Oncology Nursing, 17 (2), 138–144. doi:10.1188/13.CJON.138-144 Treister, N., Nieder, M., Baggott, C., Olson, E., Chen, L., Dang, H., . . . Sung, L. (2017). Caphosol for prevention of oral mucositis in pediatric myeloablative haematopoietic cell transplantation. British Journal of Cancer, 116 (1), 21–27. doi:10.1038/bjc.2016.380 Trovillion, E. M., Schubert, L., & Dietz, A. C. (2017). Iron overload in survivors of childhood cancer. Journal of Pediatric Hematology Oncology . doi:10.1097/MPH.0000000000000887 Troxell, M. L., Higgins, J. P., & Kambham, N. (2016). Antineoplastic treatment and renal injury: An update on renal pathology due to cytotoxic and targeted therapies. Advances in Anatomic Pathology, 23 (5), 310–329. doi:10.1097/PAP.0000000000000122 U.S. Food and Drug Administration. (2017). Information on Erythropoiesis-Stimulating Agents (ESA) Epoetin alfa (marketed as Procrit, Epogen), Darbepoetin alfa (marketed as Aranesp). Extraído de: www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ucm109375. htm Van As, J. W., van den Berg, H. e van Dalen, E. C. (2016). Platinum-induced hearing loss after treatment for childhood cancer. Cochrane Database Systematic Review, 2016 (8), 1–72. doi:10.1022/14651858.CD010181.pub2 Van Hulst, R. A., Rietbroek, R. C., Gaastra, M. T. e Schlösser, N. J. (2011). To dive or not to dive with bleomycin: A practical algorithm. Aviation, Space, and Environmental Medicine, 82 (8), 814–818. doi:10.3357/ASEM.2816.2011 Versluys, A. B. e Bresters, D. (2016). Pulmonary complications of childhood cancer treatment. Paediatric Respiratory Reviews, 17, 63–70. doi:10.1016/j.prrv.2015.09.004 Vogel, W. H. (2010). Infusion reactions: Diagnosis, assessment, and management. Clinical Journal of Oncology Nursing, 14 (2), E10–E21. doi:10.1188/10.CJON.E10-E21 Washington State University Drug Information Center. (2015). Highlights of FDA activities 11/1/15–11/30/2015 . Extraído de: https://www. pharmacy.wsu.edu/facultyexperts/druginfocenter/newsletter/ november2015.pdf Weber, J., Yang, J. C., Atkins, M. B. e Disis, M. L. (2015). Toxicities of immunotherapy for the practitioner. Journal of Clinical Oncology, 33 (18), 2092–2099. doi:10.1200/JCO.2014.60.0379 Weinstein, R. (2016). Red blood cell transfusion: A pocket guide for the clinician. American Society of Hematology. Extraído de: www. hematology.org/Clinicians/Guidelines-Quality/Quick-Ref/6976.aspx Wickham, R. (2007). Chemotherapy-induced peripheral neuropathy: A review and implications for oncology nursing practice. Clinical Journal of Oncology Nursing, 11 (3), 361–376. doi:10.1188/07. CJON.361-376 Wiernikowski, J. T. e Athale, U. H. (2006). Thromboembolic complications in children with cancer. Thrombosis Research, 118 (1), 137–152. doi:10.1016/j.thromres.2005.06.004 Wong, R. K., Bensadoun, R. J., Boers-Doets, C. B., Bryce, J., Chan, A., Epstein, J. B., . . . Lacouture, M. E. (2013). Clinical practice guidelines for the prevention and treatment of acute and late radiation reactions from the MASCC skin toxicity study group. Supportive Care in Cancer, 21 (10), 2933–2948. doi:10.1007/s00520-013-1896-2 World Health Organization. (2016a). Infertility definitions and terminology . Extraído de: http://www.who.int/reproductivehealth/
topics/infertility/definitions/en/.http://www.who.int/ reproductivehealth/topics/infertility/definitions/en/
286 Plano de Estudos de Quimioterapia e Bioterapia Pediátrica: Quarta Edição
Powered by FlippingBook